3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
NIH
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Prostatic Neoplasms
8
Breast Neoplasms
8
Neoplasms
7
Depression
6
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Follicular
5
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasm Metastasis
3
Multiple Myeloma
3
Lymphoma, Mantle-Cell
3
Lymphoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Head and Neck Neoplasms
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Anxiety Disorders
3
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Prostatic Hyperplasia
2
Myeloproliferative Disorders
2
Myelodysplastic Syndromes
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma, B-Cell, Marginal Zone
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Kidney Neoplasms
2
Fatigue
2
Interventions
thymoglobulin
1
fludarabine phosphate
1
fludarabine
1
decitabine and cedazuridine drug combination
1
cedazuridine
1
Therapeutics
1
Specimen Handling
1
Pluvicto
1
Peripheral Blood Stem Cell Transplantation
1
Interleukin-8
1
HuMax-IL8
1
Granulocyte Colony-Stimulating Factor
1
Genetic Counseling
1
Filgrastim
1
Exercise
1
Emapalumab
1
Decitabine
1
DNA
1
Cyclophosphamide
1
Busulfan
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cytopenia
×
Therapeutics
×
1 year
×
Clear all
NCT02775383
2026-02-03
MDS
National Heart, Lung, and Blood Institute (NHLBI)
Completed
2,115 enrolled